Brain cell type specificity and gliosis-induced activation of the human cytomegalovirus immediate-early promoter in transgenic mice

Journal of Neuroscience

Volumn 16, Issue 7, 1996, Pages 2275-2282

  Fritschy, Jean Marc ^a   Brandner, Sebastian ^b   Aguzzi, Adriano ^b   Koedood, Marieke ^a,c   Lüscher, Bernhard ^a   Mitchell, Pamela J ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c Boston University   (United States)

Author keywords

AIDS; astrocytes; blood brain barrier; brain specific transcription; congenital HCMV infection; encephalitis; gliosis; HCMV major immediate early promoter; viral pathogenesis

Indexed keywords

BETA GALACTOSIDASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CELL; CELL TYPE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; GENE ACTIVATION; GLIOSIS; HUMAN CYTOMEGALOVIRUS; IMMEDIATE EARLY GENE; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; TRANSGENIC MOUSE; VIRUS ENCEPHALITIS;

EID: 0029931197     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.16-07-02275.1996     Document Type: Article

References (35)

1. Alford CA, Britt WJ (1990) Cytomegalovirus. In: Virology, 2nd Ed (Fields BN, Knipe M, eds), pp 1981-2010. New York: Raven.
2. Bale JF (1984) Human cytomegalovirus infection and disorders of the nervous system. Arch Neurol 41:310-320.
3. Bignami A, Dahl D, Rueger DC (1980) Glial fibrillary acidic protein (GFA) in normal neural cells and in pathological conditions. Adv Cell Neurobiol 1:285-310.
4. Boyes BE, Kim SU, Lee V, Sung SC (1986) Immunohistochemical colocalisation of S100β and the glial fibrillary acidic protein in rat brain. Neuroscience 17:857-865.
5. Brenner M (1994) Structure and transcriptional regulation of the GFAP gene. Brain Pathol 4:245-257.
6. Eng LF, Ghirnikar RS (1994) GFAP and astrogliosis. Brain Pathol 4:229-237.
7. Fiala M, Graves MC, Grody WW, Vinters HV (1993) Role of cytomegalovirus infection in acquired immunodeficiency syndrome, with emphasis on neurological and ophthalmological complications. In: Molecular aspects of human cytomegalovirus diseases (Becker Y, Durai G, Huang E-S, eds), pp 128-149. Berlin: Springer.
8. A-receptor subtypes during postnatal development: an immunohistochemical study. J Neurosci 14:5302-5324.
9. Ghazal P, Nelson JA (1993) Transcription factors and viral regulatory proteins as potential mediators of human cytomegalovirus pathogenesis. In: Molecular aspects of human cytomegalovirus diseases (Becker Y, Durai G, Huang E-S, eds), pp 360-383. Berlin: Springer.
10. Grefte A, van der Giessen M, van Son W, The TH (1993) Circulating cytomegalovirus (CMV)-infected endothelial cells in patients with active CMV infection. J Infect Dis 167:270-277.
11. Haymaker W, Girdany BR, Stephens J, Lillie RD, Fetterman GH (1954) Cerebral involvement with advance periventricular calcification in generalized cytomegalic inclusion disease in the newborn. J Neuropathol Exp Neurol 13:562-586.
12. Ho WZ, Harouse JM, Rando RF, Gonczol E, Srinivasan A, Plotkin SA (1990) Reciprocal enhancement of gene expression and viral replication between human cytomegalovirus and human immunodeficiency virus type 1. J Gen Virol 71:97-103.
13. Hsu SM, Raine L, Fanger H (1981) Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29:577-580.
14. Huang E-S, Kowalik TF (1993) The pathogenicity of human cytomegalovirus: an overview. In: Molecular aspects of human cytomegalovirus diseases (Becker Y, Durai G, Huang E-S, eds). pp 3-45. Berlin: Springer.
15. Jay V, Becker LE, Otsubo H, Cortez M, Hwang P, Hoffman HJ, Zielenska M (1995) Chronic encephalitis and epilepsy (Rasmussen's encephalitis): detection of cytomegalovirus and herpes simplex 1 by the polymerase chain reaction and in situ hybridization. Neurology 45:108-117.
16. Klatt EC, Shibata D (1988) Cytomegalovirus infection in the acquired immunodeficiency syndrome. Arch Pathol Lab Med 112:540-544.
17. Koedood M, Fichtel A, Meier P, Mitchell PJ (1995) Human cytomegalovirus (HCMV) immediate-early enhancer/promoter specificity during embryogenesis defines target tissues of congenital HCMV infection. J Virol 69:2194-2207.
18. Lathey JL, Wiley CA, Verity MA, Nelson JA (1990) Cultured human brain endothelial cells are permissive for infection by human cytomegalovirus. Virology 176:266-273.
19. Matus A, Bernhardt R, Hugh-Jones T (1981) High molecular weight microtubule associated protein are preferentially associated with dendritic microtubules in brain. Proc Natl Acad Sci USA 78:3013-3014.
20. Nelson JA, Reynolds-Kohler C, Oldstone MBA, Wiley CA (1988) HIV and HCMV coinfect brain cells in patients with AIDS. Virology 165:286-290.
21. Perlman JA, Argyle C (1992) Lethal cytomegalovirus infection in preterm infants: clinical, radiological, neurological findings. Ann Neurol 31:64-68.
22. Poland SD, Costello P, Dekaban GA, Rice GPA (1990) Cytomegalovirus in the brain: in vitro infection of human brain-derived cells. J Infect Dis 162:1252-1262.
23. A/benzodiazepine receptors: cellular and subcellular localization in the CNS with monoclonal antibodies. J Neurosci 7:1866-1886.
24. Rogers SW, Andrews PI, Gahring LC, Whisenand T, Cautley K, Crain B, Hughes TE, Heinemann SF, McNamara JO (1994) Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephalitis. Science 265:648-651.
25. Saigal S, Lunyk O, Larke RPB, Chernesky MA (1982) The outcome in children with congenital cytomegalovirus infection. Am J Dis Child 136:896-901.
26. Skolnik PR, Kosloff BR, Hirsch MS (1988) Bidirectional interactions between human immunodeficiency virus type 1 and cytomegalovirus. J Infect Dis 157:508-514.
27. Twyman RE, Gahring LC, Spiess J, Rogers SW (1995) Glutamate receptor antibodies activate a subset of receptors and reveal an agonist binding site. Neuron 14:755-762.
28. Vinters HV, Ferreiro JA (1993) Pathology of human cytomegalovirus infection. In: Molecular aspects of human cytomegalovirus diseases (Becker Y, Durai G, Huang E-S, eds), pp 46-71. Berlin: Springer.
29. Vinters HV, Kwok MK, Ho HW, Anders KH, Tomiyasu U, Wolfson WL, Robert F (1989) Cytomegalovirus in the nervous system of patients with the acquired immune deficiency syndrome. Brain 119:245-268.
30. Vogel FS (1958) Enhanced susceptibility of proliferating endothelium to salivary gland virus under naturally occurring and experimental conditions. Am J Pathol 34:1069-1075.
31. Waldman WJ, Knight DA, Huang E, Sedmak D (1995) Bidirectional transmission of infectious cytomegalovims between monocytes and vascular endothelial cells: an in vitro model. J Infect Dis 171:263-272.
32. Wiley CA, Nelson JA (1988) Role of human immunodeficiency virus and cytomegalovirus in AIDS encephalitis. Am J Pathol 133:73-81.
33. Wiley CA, Nelson JA (1993) Role of cytomegalovirus infection in neurologic abnormalities of acquired immunodeficiency syndrome. In: Molecular aspects of human cytomegalovirus diseases (Becker Y, Durai G. Huang E-S, eds), pp 119-127. Berlin: Springer.
34. Wiley CA, Schrier RD, Denaro FJ, Nelson JA, Lampen PW, Oldstone MBA (1986) Localization of cytomegalovirus proteins and genome during fulminant central nervous system infection in an AIDS patient. J Neuropathol Exp Neurol 25:127-139.
35. Worth WA, Howard HL (1950) New features of inclusion disease of infancy. Am J Pathol 26:17-35.